Arterra Bioscience SpA (MIL:ARBS) Beta: 0.0826 (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:ARBS Arterra Bioscience SpA MIL:ARBS
77 GF Score
Price €3.04
GF Value €2.91
Valuation Fairly Valued
View Full Analysis

What is Arterra Bioscience SpA Beta?

Arterra Bioscience SpA MIL:ARBS -0.33% 77 Beta is 0.0826 as of Jul. 18, 2026. GuruFocus rates MIL:ARBS with a GF Score™ of 77/100 and a GF Value™ of €2.91 (Fairly Valued).

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-07-18), Arterra Bioscience SpA's Beta is 0.0826.


Arterra Bioscience SpA  (MIL:ARBS) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Arterra Bioscience SpA Beta Related Terms


Arterra Bioscience SpA Beta Historical Data

* Premium members only.

The historical data trend for Arterra Bioscience SpA's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arterra Bioscience SpA Beta Chart

Arterra Bioscience SpA Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.83 0.83 -0.04 0.17

Arterra Bioscience SpA Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 0.84 -0.04 0.62 0.17

MIL:ARBS vs VRTX, REGN, ALNY: Beta Comparison

For the Biotechnology subindustry, Arterra Bioscience SpA's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arterra Bioscience SpA Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arterra Bioscience SpA's Beta distribution charts can be found below:

* The bar in red indicates where Arterra Bioscience SpA's Beta falls into.


MIL:ARBS
77GF Score
Arterra Bioscience SpA MIL:ARBS
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arterra Bioscience SpA Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.0826 mean?
Arterra Bioscience SpA (MIL:ARBS) has a Beta of 0.0826 as of Jul. 18, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arterra Bioscience SpA and its competitors.
Is Arterra Bioscience SpA's Beta too high?
Arterra Bioscience SpA's current Beta is 0.0826. Overall, Arterra Bioscience SpA has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Arterra Bioscience SpA's Beta compare to VRTX and REGN?
Arterra Bioscience SpA's Beta of 0.0826 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Arterra Bioscience SpA and its competitors. Arterra Bioscience SpA's current Beta is 0.0826. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arterra Bioscience SpA stock overvalued right now?
Based on GuruFocus' analysis, Arterra Bioscience SpA (MIL:ARBS) is currently considered Fairly Valued. The stock's GF Value™ is €2.91, compared to a current price of €3.04 — trading 4.5% above its estimated fair value. The current Beta is 0.0826. Arterra Bioscience SpA's overall GF Score™ is 77/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Arterra Bioscience SpA (MIL:ARBS), the current Beta is 0.0826 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Arterra Bioscience SpA (MIL:ARBS) Overvalued in 2026?

Based on GuruFocus' analysis, Arterra Bioscience SpA stock appears to be overvalued. The current stock price of €3.04 is trading 4.5% above its estimated GF Value™ of €2.91. GuruFocus considers Arterra Bioscience SpA to be Fairly Valued.

Key valuation signals for MIL:ARBS:

  • Beta: 0.0826
  • GF Value™: €2.91 vs. price of €3.04 (4.5% above fair value)
  • GF Score™: 77/100

No single metric tells the full story. See the MIL:ARBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Arterra Bioscience SpA Business Description

Address via Benedetto Brin, 69, Napoli, ITA, 80142
Arterra Bioscience SpA is a biotechnology company focused on the research and development of ingredients and natural solutions. It engages in the development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds; and production of high-tech raw materials with application in different industrial fields.
77GF Score

Get the complete analysis for MIL:ARBS

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.04
Price
€2.91
GF Value